Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Assistance Publique - Hôpitaux de Paris
Rigshospitalet, Denmark
Hospital Universitario Araba
Emory University